Cheng HW - Search Results

1

Manipulating the Crosstalk between Cancer and Immunosuppressive Cells with Phototherapeutic Gold-Nanohut for Reprogramming Tumor Microenvironment.

Cheng HW, Lee W, Hsu FT, Lai YH, Huang SR, Lim CSH, Lin ZK, Hsu SC, Chiang CS, Jeng LB, Shyu WC, Chen SY. Cheng HW, et al. Adv Sci (Weinh). 2024 Aug;11(32):e2404347. doi: 10.1002/advs.202404347. Epub 2024 Jun 23. Adv Sci (Weinh). 2024. PMID: 38923327 Free PMC article.

2

Combination of fucoidan-based magnetic nanoparticles and immunomodulators enhances tumour-localized immunotherapy.

Chiang CS, Lin YJ, Lee R, Lai YH, Cheng HW, Hsieh CH, Shyu WC, Chen SY. Chiang CS, et al. Among authors: cheng hw. Nat Nanotechnol. 2018 Aug;13(8):746-754. doi: 10.1038/s41565-018-0146-7. Epub 2018 May 14. Nat Nanotechnol. 2018. PMID: 29760523

3

Circulating tumor-cell-targeting Au-nanocage-mediated bimodal phototherapeutic properties enriched by magnetic nanocores.

Chiang CS, Kao YC, Webster TJ, Shyu WC, Cheng HW, Liu TY, Chen SY. Chiang CS, et al. Among authors: cheng hw. J Mater Chem B. 2020 Jul 1;8(25):5460-5471. doi: 10.1039/d0tb00501k. J Mater Chem B. 2020. PMID: 32462165

4

Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs.

Lai YH, Chiang CS, Hsu CH, Cheng HW, Chen SY. Lai YH, et al. Among authors: cheng hw. Biomolecules. 2020 Jun 28;10(7):970. doi: 10.3390/biom10070970. Biomolecules. 2020. PMID: 32605162 Free PMC article.

5

Advances in Magnetic Nanoparticle-Mediated Cancer Immune-Theranostics.

Cheng HW, Tsao HY, Chiang CS, Chen SY. Cheng HW, et al. Adv Healthc Mater. 2021 Jan;10(1):e2001451. doi: 10.1002/adhm.202001451. Epub 2020 Nov 1. Adv Healthc Mater. 2021. PMID: 33135398 Review.

6

Stem cell-nanomedicine system as a theranostic bio-gadolinium agent for targeted neutron capture cancer therapy.

Lai YH, Su CY, Cheng HW, Chu CY, Jeng LB, Chiang CS, Shyu WC, Chen SY. Lai YH, et al. Among authors: cheng hw. Nat Commun. 2023 Jan 18;14(1):285. doi: 10.1038/s41467-023-35935-0. Nat Commun. 2023. PMID: 36650171 Free PMC article.

7

Dextran-modified Quercetin-Cu(II)/hyaluronic acid nanomedicine with natural poly(ADP-ribose) polymerase inhibitor and dual targeting for programmed synthetic lethal therapy in triple-negative breast cancer.

Cheng HW, Chiang CS, Ho HY, Chou SH, Lai YH, Shyu WC, Chen SY. Cheng HW, et al. J Control Release. 2021 Jan 10;329:136-147. doi: 10.1016/j.jconrel.2020.11.061. Epub 2020 Dec 2. J Control Release. 2021. PMID: 33278482

8

Dual-Sensitive Gold-Nanocubes Platform with Synergistic Immunotherapy for Inducing Immune Cycle Using NIR-Mediated PTT/NO/IDO.

Tsao HY, Cheng HW, Kuo CC, Chen SY. Tsao HY, et al. Among authors: cheng hw. Pharmaceuticals (Basel). 2022 Jan 25;15(2):138. doi: 10.3390/ph15020138. Pharmaceuticals (Basel). 2022. PMID: 35215251 Free PMC article.

9

Electrogelated drug-embedded silk/gelatin/rGO degradable electrode for anti-inflammatory applications in brain-implant systems.

Lin ZK, Lin JS, Chen ZH, Cheng HW, Huang WC, Chen SY. Lin ZK, et al. Among authors: cheng hw. J Mater Chem B. 2024 Jan 31;12(5):1361-1371. doi: 10.1039/d3tb02715e. J Mater Chem B. 2024. PMID: 38234194

10

The Treatment of Keloid Scars via Modulating Heterogeneous Gelatin-Structured Composite Microneedles to Control Transdermal Dual-Drug Release.

Chen YJ, Cheng HW, Yen WY, Tsai JH, Yeh CY, Chen CJ, Liu JT, Chen SY, Chang SJ. Chen YJ, et al. Among authors: cheng hw. Polymers (Basel). 2022 Oct 20;14(20):4436. doi: 10.3390/polym14204436. Polymers (Basel). 2022. PMID: 36298014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters